Evidence map›Paper›PMID 29348794›Full record

ArticleInternational journal of physiology, pathophysiology and pharmacology2017

Tubby-like protein 1 (Tulp1) is a target of microRNA-134 and is down-regulated in experimental epilepsy.

Amaya Sanz Rodriguez, Tobias Engel, Arpad Palfi, G Jane Farrar, David C Henshall, Eva M Jimenez-Mateos

Open access · greenAbstract read
In one paragraph

Article in International journal of physiology, pathophysiology and pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Aberrant expression of miRNAs in epilepsy.Molecular biology reports · 2022
    Review
  2. Article
  3. Article
  4. von Willebrand factor rescued byBioscience reports · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Amaya Sanz RodriguezDepartment of Physiology & Medical Physics, Royal College of Surgeons in IrelandDublin 2, Ireland.
Tobias EngelDepartment of Physiology & Medical Physics, Royal College of Surgeons in IrelandDublin 2, Ireland.
Arpad PalfiSmurfit Institute of Genetics, School of Genetics and Microbiology and Trinity College Institute of Neuroscience, Trinity College DublinDublin 2, Ireland.
G Jane FarrarSmurfit Institute of Genetics, School of Genetics and Microbiology and Trinity College Institute of Neuroscience, Trinity College DublinDublin 2, Ireland.
David C HenshallDepartment of Physiology & Medical Physics, Royal College of Surgeons in IrelandDublin 2, Ireland.
Eva M Jimenez-MateosDepartment of Physiology & Medical Physics, Royal College of Surgeons in IrelandDublin 2, Ireland.
Royal College of Surgeons in Ireland · IETrinity College · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are important determinants of gene expression via post-transcriptional control of the protein levels of their mRNA targets. MicroRNA-134 (miR-134) has emerged as an important brain-specific microRNA which has been implicated in the control of dendritic spine morphology, neuronal differentiation and apoptosis. Here we show that Tubby-like protein 1 (Tulp1) is a target of miR-134. Tulp1 protein showed a similar cellular distribution pattern in the hippocampus to miR-134 and displayed an inverse expression pattern in the mouse retina. Bioinformatics analyses identified a conserved miR-134 binding site in the 3' untranslated region of both mouse and human

Indexed as

Epilepsyhippocampal sclerosisnon-coding RNAstatus epilepticus

Identifiers

PMID29348794
PMCPMC5770514
OpenAlexW2999313206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.